Citigroup Inc Evaxion Biotech A/S Put Options Transaction History
Citigroup Inc
- $153 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EVAX
# of Institutions
1Shares Held
37.5KCall Options Held
0Put Options Held
0About Evaxion Biotech A/S
- Ticker EVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,977,900
- Market Cap $71.2M
- Description
- Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...